Skip to content
JournalsWorldThe Global Research Discovery Platform
Login Sign Up

Academic Journal

Q3

Expert Review of Precision Medicine and Drug Development

Taylor and Francis Ltd.

United KingdomPharmacology (Q3); Drug Discovery (Q4); Genetics (Q4); Molecular Medicine (Q4)ISSN-matched source record
Journal website ↗
Q3Ranking
—Impact Factor (year unverified)
19H-index (SCImago 2025)
0.25SJR (2025)
2016-2025Coverage

About Expert Review of Precision Medicine and Drug Development

Expert Review of Precision Medicine and Drug Development is a scholarly journal published by Taylor and Francis Ltd.. SCImago 2025 lists it in Q3, with an SJR of 0.25 and H-index of 19.

Coverage: 2016-2025. Research categories: Pharmacology (Q3); Drug Discovery (Q4); Genetics (Q4); Molecular Medicine (Q4).

Source-backed journal facts

ISSN(s)2380-8993
ISSN-L2380-8993
Source typeJournal
Publisher / hosting organisationTaylor & Francis
Publisher country codeGB
Fully open access (OpenAlex)Not marked as fully open access; hybrid options may exist
DOAJ flag (OpenAlex)Not listed in OpenAlex metadata; this is not a direct DOAJ check
Works recorded in OpenAlex282
Citations recorded in OpenAlex3,138
OpenAlex H-index22
Years represented in OpenAlex2016–2025 (not the founding or closing dates)

Topics in published research

Cancer Genomics and Diagnostics; Cancer Immunotherapy and Biomarkers; Lung Cancer Treatments and Mutations; Pharmacogenetics and Drug Metabolism; Colorectal Cancer Treatments and Studies; CAR-T cell therapy research.

OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.

Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.

Found incorrect or outdated information?Help us keep this profile accurate.
Suggest an Edit